🇺🇸 Neutral protamine hagedorn insulin in United States

39 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cardiac Arrest — 8 reports (20.51%)
  2. Drug Interaction — 6 reports (15.38%)
  3. Seizure — 5 reports (12.82%)
  4. Toxicity To Various Agents — 5 reports (12.82%)
  5. Overdose — 4 reports (10.26%)
  6. Vomiting — 3 reports (7.69%)
  7. Accidental Overdose — 2 reports (5.13%)
  8. Coma — 2 reports (5.13%)
  9. Hyperkalaemia — 2 reports (5.13%)
  10. Intracardiac Thrombus — 2 reports (5.13%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Neutral protamine hagedorn insulin approved in United States?

Neutral protamine hagedorn insulin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Neutral protamine hagedorn insulin in United States?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.